Trials / Completed
CompletedNCT01744366
One Month Degarelix/Comparator Treatment for Prostate Cancer in Chinese Population
An Open-label, Multi-centre, Randomised, Parallel-group Trial, Comparing Efficacy and Safety of Degarelix One-month Dosing Regimen With Goserelin in Chinese Patients With Prostate Cancer Requiring Androgen Ablation Therapy
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 285 (actual)
- Sponsor
- Ferring Pharmaceuticals · Industry
- Sex
- Male
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
One month degarelix/comparator treatment for prostate cancer in Chinese population
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Degarelix | |
| DRUG | Goserelin |
Timeline
- Start date
- 2013-01-01
- Primary completion
- 2015-05-01
- Completion
- 2015-05-01
- First posted
- 2012-12-06
- Last updated
- 2015-06-23
Locations
29 sites across 1 country: China
Source: ClinicalTrials.gov record NCT01744366. Inclusion in this directory is not an endorsement.